COSETTE Company Profile

✉ Email this page to a colleague

COSETTE has one hundred and eighteen approved drugs.

There are five US patents protecting COSETTE drugs.

There are seventy-six patent family members on COSETTE drugs in twenty-six countries and ninety-one supplementary protection certificates in fourteen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cosette	CAPTOPRIL	captopril	TABLET;ORAL	074433-001	Feb 13, 1996		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Cosette	BETAMETHASONE DIPROPIONATE	betamethasone dipropionate	LOTION;TOPICAL	071882-001	Jun 6, 1988		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Cosette	CLINDAMYCIN HYDROCHLORIDE	clindamycin hydrochloride	CAPSULE;ORAL	063029-001	Sep 20, 1989		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cosette	EFFIENT	prasugrel hydrochloride	TABLET;ORAL	022307-001	Jul 10, 2009	6,693,115	⤷ Sign Up
Cosette	BENICAR HCT	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	021532-002	Jun 5, 2003	5,616,599*PED	⤷ Sign Up
Cosette	WELCHOL	colesevelam hydrochloride	CAPSULE;ORAL	021141-001	May 26, 2000	6,433,026*PED	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	625 mg	➤ Subscribe	2009-07-01
➤ Subscribe	Capsules	30 mg	➤ Subscribe	2009-02-27
➤ Subscribe	Tablets	10 mg/20 mg and 5 mg/40 mg	➤ Subscribe	2008-03-31
➤ Subscribe	Tablets	20 mg/12.5 mg	➤ Subscribe	2007-05-11
➤ Subscribe	Tablets	5 mg and 10 mg	➤ Subscribe	2013-07-10
➤ Subscribe	Powder for Oral Suspension	1.875 g/Packet and 3.75 g/Packet	➤ Subscribe	2010-04-09
➤ Subscribe	Tablets	5 mg/20 mg and 10 mg/40 mg	➤ Subscribe	2008-02-11
➤ Subscribe	Tablets	5 mg, 20 mg and 40 mg	➤ Subscribe	2006-04-25
➤ Subscribe	Tablets	40 mg/12.5 mg and 40 mg/25 mL	➤ Subscribe	2007-02-15

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Canada	2453515	⤷ Sign Up
Poland	2916856	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2005014617	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0565634	06C0030	France	⤷ Sign Up	PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607
0031058	98C0008	Belgium	⤷ Sign Up	PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203
1003503	05C0048	France	⤷ Sign Up	PRODUCT NAME: AMLODIPINE OU UN DE SES SELS D?ADDITION D?ACIDES PHARMACAUTIQUEMENT ACCEPTABLES/ ATORVASTATINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: NL 29929 DU 20050707; REGISTRATION NO/DATE AT EEC: NL 29929 DU 20050707
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.